Journal of the American Association of Nurse Practitioners
Journal of the American Association of Nurse Practitioners
Audio Summaries
Every issue of Journal of the American Association of Nurse Practitioners moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
Journal of the American Association of Nurse Practitioners covers research in these specialties.
Recent summaries
The latest articles summarized from Journal of the American Association of Nurse Practitioners.
Recognizing repeat expansion disorders in clinical practice
Jun 11, 2026
The authors aim to highlight the importance of recognizing repeat expansion disorders in clinical practice, emphasizing the role of healthcare providers in identifying early symptoms and making timely referrals for genetic evaluation. They discuss the variability in clinical presentations and the molecular characteristics that influence disease severity, underscoring the need for awareness of these conditions to facilitate early intervention and support for affected families. The paper also notes the potential for emerging gene-targeted therapies to modify disease progression.
Comparing prescribing practices of nurse practitioners and physicians in the United States: A scoping review
Jun 10, 2026
This scoping review aims to synthesize current evidence on the prescribing practices of nurse practitioners (NPs) compared to physicians in the United States, focusing on quality, patterns, and trends. The findings indicate that while NP prescribing quality is generally comparable to that of physicians, variations exist based on medication type and practice setting, with NPs showing increased prescribing in certain areas and a slower adoption of new medications. The study underscores the need for tailored resources to support NP prescribing roles in diverse clinical contexts.
Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review
Jun 6, 2026
The authors conducted a systematic review to evaluate the efficacy and potential benefits of second-generation incretin analogs, specifically semaglutide and tirzepatide, in treating type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). They identified 11 relevant studies, highlighting issues such as diagnostic challenges for LADA and the promising, though moderate-quality, evidence supporting the use of these medications in patients with residual beta-cell function. The review emphasizes the need for well-designed randomized trials to better understand the long-term effects of these treatments in clearly defined patient populations.